From c477f62983561161f8481a2296b91245195a0fba Mon Sep 17 00:00:00 2001 From: FMS Date: Thu, 4 Apr 2024 16:18:17 +0200 Subject: [PATCH] Auto saved by Logseq --- journals/2024_04_04.md | 3 +++ 1 file changed, 3 insertions(+) diff --git a/journals/2024_04_04.md b/journals/2024_04_04.md index bdd7cdf1..4b1ec1ce 100644 --- a/journals/2024_04_04.md +++ b/journals/2024_04_04.md @@ -45,6 +45,9 @@ - Liconsa responsability. - Liconsa tiene track record en gloabl health porque hacen el benznidazol y han prequalified ivermectin. - ISGlobal lidership de las biomedical sciences. + - WP3 leaded by KEMRI: leaded by modelling and db but also as a siste. + - wp4: the social sciences: acceptabiility feasibility and adherence: also clinical site, but also a leader through their expertise on other projects on acceptaibility. + - WP5: - - - ## Cosas de gastos del [[Evento]]